Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$5.57 - $7.66 $1.76 Million - $2.42 Million
-315,404 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$3.34 - $9.8 $16,609 - $48,735
-4,973 Reduced 1.55%
315,404 $2.31 Million
Q1 2020

May 15, 2020

SELL
$1.7 - $22.5 $3,495 - $46,260
-2,056 Reduced 0.64%
320,377 $589,000
Q4 2019

Feb 14, 2020

SELL
$15.4 - $21.9 $39,531 - $56,217
-2,567 Reduced 0.79%
322,433 $5.16 Million
Q2 2019

Aug 14, 2019

BUY
$15.37 - $27.15 $5 Million - $8.82 Million
325,000 New
325,000 $8.82 Million

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $70.8M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.